Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports
Health Populi
MARCH 13, 2018
Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure.
168 
Let's personalize your content